Malhotra A, Kang B P, Opawumi D, Belizaire W, Meggs L G
Department of Medicine, UMDNJ-New Jersey Medical School, Newark 07103, USA.
Mol Cell Biochem. 2001 Sep;225(1-):97-107. doi: 10.1023/a:1012261903611.
The PKC family of serine/threonine kinases have been implicated in a diverse array of cellular responses. Adult cardiac myocytes express multiple PKC isozymes, which participate in the response of muscle cells to extracellular stimuli, modulate contractile properties, and promote cell growth and survival. Recently, the classification of this ubiquitous family of signaling molecules has been expanded from three to four subfamilies. This review will focus on the application of pharmacologic and molecular approaches to explore the biology of cardiac PKC isozymes. The availability of transgenic mice and peptide PKC modulators have been instrumental in identifying target substrates for activated cardiac PKC isozymes, as well as the identification of specific isozymes linked to distinct growth characteristics and cell phenotype. The rapid growth of knowledge in the area of PKC signaling and PKC substrate interactions, may result in the development of therapeutic modalities with the potential to arrest or reverse the progression of cardiovascular diseases.
丝氨酸/苏氨酸激酶的蛋白激酶C(PKC)家族与多种细胞反应有关。成年心肌细胞表达多种PKC同工酶,它们参与肌肉细胞对细胞外刺激的反应,调节收缩特性,并促进细胞生长和存活。最近,这个普遍存在的信号分子家族的分类已从三个亚家族扩展到四个亚家族。本综述将重点关注药理学和分子学方法在探索心脏PKC同工酶生物学方面的应用。转基因小鼠和肽PKC调节剂的可用性有助于识别活化的心脏PKC同工酶的靶底物,以及识别与不同生长特征和细胞表型相关的特定同工酶。PKC信号传导和PKC底物相互作用领域知识的快速增长,可能会促成具有阻止或逆转心血管疾病进展潜力的治疗方法的开发。